Marked decrease of serum Ca 125 levels after denver shunt placement in a patient with cirrhosis and refractory ascites

Digestive Diseases and Sciences

Volumn 51, Issue 9, 2006, Pages 1644-1646

  Leggio, L ^a   Abenavoli, L ^a   D'Angelo, C ^a   Ferrulli, A ^a   Vonghia, L ^a   Mirijello, A ^a   Barbarino, R ^a   De Michele, T ^a   Zuppi, C ^a   Gui, D ^a   Rapaccini, G L ^a   Gasbarrini, G ^a   Addolorato, G ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Cancer antigen 125; Denver shunt; Liver cirrhosis; Refractory ascites

Indexed keywords

ALBUMIN; ALPHA FETOPROTEIN; AMYLASE; CA 125 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CREATININE;

ADULT; ANAMNESIS; ARTICLE; ASCITES; BRAIN DISEASE; CASE REPORT; CLINICAL FEATURE; HUMAN; LIVER CIRRHOSIS; MALE; PRIORITY JOURNAL; SHUNTING; SYMPTOMATOLOGY;

ASCITES; CA-125 ANTIGEN; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PERITONEOVENOUS SHUNT; TREATMENT OUTCOME;

EID: 33748591116     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-006-9115-3     Document Type: Article

References (14)

1. Molina R, Filella X, Bruix J, Mengual P, Bosch J, Calvet X, Jo J, Ballista AM (1991) Cancer antigen CA 125 in serum and ascitic fluid of patients with liver diseases. Clin Chem 37:1379-1383
2. Collazos J, Genolla J, Ruibal A (1992) CA 125 serum levels in patients with non-neoplastic liver disease. A clinical and laboratory study. Scand J Clin Lab Invest 52:201-206
3. Kadayifci A, Simsek H, Savas MC, Toppare M (1996) Serum tumor markers in chronic liver disease. Neoplasma 43:17-21
4. DiBaise JK, Donovan JP (1999) Markedly elevated CA 125 in hepatic cirrhosis : two case illustrations and review of the literature. J Clin Gastroenterol 28:159-161
5. Zuckerman E, Lanir A, Sabo E, Rosenvald-Zuckerman T, Matter I, Yeshurun D, Eldar S (1999) Cancer antigen 125: a sensitive marker of ascites in patientswith liver cirrhosis. Am J Gastroenterol 94:1613-1618
6. Deschenes M, Michel RP, Alpert E, Barkun JS, Metrakos P, Tchervenkov J (2001) Elevation of CA-125 level is due to abdominal distension in liver transplantation candidates. Transplantation 72:1519-1522
7. Sari R, Yildirim B, Sevinc A, Hilmioglu F (2001) Re. Zuckerman et al. - Sensitivity of Ca 125 in patients with liver cirrhosis in the presence of ascites. Am J Gastroenterol 96:253-254 and 1319 (erratum)
8. Xiao W-B, Liu Y-L (2003) Elevation of serum and ascites cancer antigen 125 levels in patients with liver cirrhosis. J Gastroenterol Hepatol 18:1315-1316
9. Sevinc A, Camci C, Turk HM, Buyukberber S (2003) How to interpret serum CA 125 levels in patients with serosal involvement? A clinical dilemma. Oncology 65:1-6
10. Uzunkoy A, Harma M, Harma M (2004) Diagnosis of abdominal tuberculosis: experience from 11 cases and review of the literature. World J Gastroenterol 10:3647-3649
11. Russo MW, Sood A, Jacobson IM, Brown RS Jr (2003) Transjugular intrahepatic portosystemic shunt for refractory ascites: an analysis of the literature on efficacy, morbidity, and mortality. Am J Gastroenterol 98:2521-2527
12. Bast RC Jr, Feeney M, Lazarus H, Nadler LM, Colvin RB, Knapp RC (1981) Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest 68:1331
13. Bergmann JF, Bidart JM, George M, Beaugrand M, Levy VG, Bohuon C (1987) Elevation of CA 125 in patients with benign and malignant ascites. Cancer 59:213-217
14. Eerdekens MW, Nouwen EJ, Pollet DE, Briers TW, DeBroe ME (1985) Placental alkaline phosphatase and cancer antigen 125 in sera of patients with benign and malignant diseases. Clin Chem 31:687-690